Leading energy efficiency consultancy EECO2 has delivered more than £10m in global energy savings to the pharmaceutical and life science sector. The energy savings are displayed on the company’s website at www.eeco2.co.uk. The savings delivered to date amount to an astounding 252,217,127kWh and 91,564 tonnes of carbon dioxide.
EECO2 has firmly established its position as a leading energy consultancy within the pharmaceutical and life sciences sector and works with global giants such as GSK, AstraZeneca, Pfizer, Lilly and Novartis.
‘The core expertise and experience within EECO2 is not the usual “Consultant” format as we all come from a design and build background, commercially grounded and totally focused upon the identification and cost effective delivery of identified energy savings,’ said founding Director Rob Wallace.
“We validate energy savings and are able to demonstrate more than £10m in savings to date.’
EECO2 uses its acquired experience and knowledge to provide cost-effective energy and emission reduction solutions from initial opportunity identification through implementation and verification of savings.
The pharmaceutical industry is heavily regulated. Historically HVAC was over-designed with consequent high running costs and carbon intensive facilities, exceeding levels required for compliance. As a result, facilities are operating in excess of the levels required for compliance at an ever-increasing cost due to energy price rises.
Energy Experts at EECO2 have identified the following key challenges for the pharmaceutical sector:
- The need to compete with low cost manufacturers
- The need to provide affordable high quality medicines to a global market place
- The need to maintain profitability
- The need to reduce carbon emissions
- The need to respond to energy and carbon reduction legislation
To remain competitive, pharmaceutical companies can no longer afford to continue to run over-compliant facilities that add no additional benefits to product quality. The EECO2 approach relies on identifying and reducing energy demand without compromising on product quality. The key to this requires the complete involvement of their clients’ key stakeholders – engineering, manufacturing, quality assurance and health and safety.
EECO2 offers the following services to the global pharmaceutical sector:
- Energy consultation
- Energy kaizens
- Bespoke site specific solutions
- Identification of viable energy savings to implementation support
- HVAC energy surveys
- Energy monitoring (MEMUs)
- Project management
- HVAC redesign to achieve savings
- Compliance documentation authoring and revision
- Fume cupboard testing to BS EN 14175
- Cleanroom commissioning (CIBSE Commissioning Code A)
- Cleanroom testing to ISO 14644 (CTCB-I certified)
- HVAC Validation
- After Action Review (AAR) to identify best practice solutions
- Sharing of global experience and best practice.
